Clinical Trial Update: Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension? [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Dundee evaluated whether PDE5A inhibitors can improve exercise capacity in patients with chronic obstruc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• PDE5A inhibitors (unspecified)

Snippet

Sponsor: University of Dundee | Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary Hypertension | Phase 2 | Status: COMPLETED